References

  1. Neustadt DH. Long-term efficacy and safety of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Clin Exp Rheumatol. 2003 May-Jun;21(3):307-11. This article on PubMed

  2. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993 Aug;39:3-9. This article on PubMed

  3. Leopold SS, Warme WJ, Pettis PD, Shott S. Increased frequency of acute local reaction to intra-articular hylan GF-20 (synvisc) in patients receiving more than one course of treatment.J Bone Joint Surg Am. 2002 Sep;84-A(9):1619-23. This article on PubMed

  4. Puttick MP, Wade JP, Chalmers A, Connell DG, Rangno KK. Acute local reactions after intraarticular hylan for osteoarthritis of the knee. J Rheumatol. 1995 Jul;22(7):1311-4. This article on PubMed

  5. Roos J, Epaulard O, Juvin R, Chen C, Pavese P, Brion JP. Acute pseudoseptic arthritis after intraarticular sodium hyaluronan. Joint Bone Spine. 2004 Jul;71(4):352-4. This article on PubMed

  6. Bernardeau C, Bucki B, Lioté F. Acute arthritis after intra-articular hyaluronate injection: onset of effusions without crystal. Ann Rheum Dis. 2001 May;60(5):518-20. This article on PubMed

  7. Pullman-Mooar S, Mooar P, Sieck M, Clayburne G, Schumacher HR. Are there distinctive inflammatory flares after hylan g-f 20 intraarticular injections? J Rheumatol. 2002 Dec;29(12):2611-4. This article on PubMed

  8. Kurosaka N, Takagi T, Koshino T. Effects of hyaluronate on CD44 expression of infiltrating cells in exudate of rat air pouch, induced by sensitization with lipopolysaccharide. J Rheumatol. 1999 Oct;26(10):2186-90. This article on PubMed

  9. Johnson BA, Haines GK, Harlow LA, Koch AE. Adhesion molecule expression in human synovial tissue. Arthritis Rheum. 1993 Feb;36(2):137-46. This article on PubMed

&n